News

BioSpace5d
FDA Rejections: We Read 200 CRLs So You Don’t Have To
A journey through the FDA’s newly released complete response letters gave glimpses into the journeys to market for Eli ...
TheHealthSite on MSN2d
What Is Lenacapavir? All About WHO Recommended Biannual HIV Prevention Drug
A breakthrough to reduce risk of HIV in adolescents and adults weighing at least 35 kg. WHO releases the new guidelines ...
Sanford specialist explains new HIV treatment
We’ve come a long way in treating HIV, the virus that can lead to AIDs. Just last month, the FDA approved a medication that ...
KESQ9h
World Health Organization calls out for help making breakthrough HIV drug accessible to the public
The World Health Organization just announced this week that they want all countries to help make a breakthrough HIV drug reach people as quickly and safely as possible. The drug's nickname is "Len," a ...
WHO recommends twice-a-year HIV prevention shot as concern looms over funding for global HIV fight
The World Health Organization is now recommending that countries include an HIV drug newly approved for prevention, ...
Managed Healthcare Executive6d
FDA Accepts NDA for Investigational HIV Regimen, Doravirine/Islatravir
If approved, doravirine/islatravir would be the first two-drug HIV treatment regimen without an integrase inhibitor, ...
OutSmart Magazine8d
FDA Approves First Twice-Yearly PrEP for HIV Prevention
Lenacapavir, the first FDA-approved, twice-yearly injectable PrEP for HIV prevention, shows 96% efficacy and offers ...
Fierce Pharma1d
GSK expands Medicines Patent Pool deal to allow generic production of cabotegravir for HIV treatment
GSK has expanded its voluntary licensing agreement with the United Nations-backed Medicines Patent Pool (MPP) for cabotegravir, allowing it to be produced by three generic drugmakers and supplied to ...